Shanghai Rightongene Biotechnology Co Ltd
688217
Company Profile
Business description
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
Contact
No. 6055, Jinhai Road
Building 3
Fengxian District
Shanghai201499
CHNT: +86 2133282601
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
336
Stocks News & Analysis
stocks
ASX iron ore player downgraded ahead of earnings
Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks
Global tensions drive profitability for ASX energy provider
Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks
ASX energy share undervalued ahead of earnings
Pricing strength outweighs temporary production headwinds.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,405.40 | 59.70 | 0.64% |
| CAC 40 | 8,665.10 | 1.53 | -0.02% |
| DAX 40 | 26,186.26 | 16.09 | -0.06% |
| Dow JONES (US) | 54,728.94 | 643.06 | 1.19% |
| FTSE 100 | 10,910.56 | 31.18 | 0.29% |
| HKSE | 25,915.82 | 62.90 | 0.24% |
| NASDAQ | 26,653.44 | 68.45 | 0.26% |
| Nikkei 225 | 66,300.44 | 2,342.91 | 3.66% |
| NZX 50 Index | 13,997.18 | 93.72 | 0.67% |
| S&P 500 | 7,771.39 | 34.87 | 0.45% |
| S&P/ASX 200 | 9,227.80 | 51.30 | 0.56% |
| SSE Composite Index | 3,878.43 | 56.15 | 1.47% |